Life Sciences Pulse
Life Sciences Pulse
Our Life Sciences Pulse strategy targets investments in innovative therapeutics, diagnostics, and life sciences tools companies.
Innovation is Accelerating
Life Sciences Pulse aims to invest in companies operating in specific business spaces and become their partners for long-term growth. Innovation is accelerating in the fields of therapeutics, diagnostics, and life sciences tools, and we often invest at their intersection. These confluences and new fields have the ability to transform how diseases are defined, diagnosed, and treated.
Our Investment Focus
U.S. based businesses
life sciences hubs
Businesses with clinical data
proof of concept
$25M – $40M
Partners for Long-term Growth
Sands Capital’s singular aim is to make long-term, concentrated investments in exceptional businesses. By leveraging our global research platform to source, assess, and structure investment opportunities, Sands Capital can partner with pioneers in the expanding class of innovative life sciences businesses and support them along their path to growth.
A Bold Mission Requires a Strong Team
Sands Capital has a single, integrated team focused on private markets, that collaborates to support the execution of the Life Sciences Pulse strategy. We have sought out individuals who share our passions and are integrated with the broader Sands Capital investment team. The Life Sciences Pulse team is comprised of senior professionals across public and private markets, with founders, operators, PhDs and experienced investors leading our team.
Michael J. Ginder, CFA
Executive Managing Partner
Executive Managing Director
Stephen Zachary, PhD
Padmaparna Chaudhuri, PhD
Director of Technical Research
Sr. Research Analyst
Sr. Research Analyst
Director, Research Associate Program
Jake Merrill, CFA
Aagam Shah, PhD
Andrew P. Giordano
Managing Director, Business Development and Client Relations
Sr. Director, Client Relations
Miriam Z. Sanders
Director, Investor Relations
Chief Compliance Officer, Sr. Counsel
Yolande J. Hanlan
Director, Sr. Counsel
Director of Compliance, Associate Counsel
As of October 1, 2021, the firm was redefined to be the combination of Sands Capital Management, LLC and Sands Capital Ventures, LLC. The two investment advisers are combined to be one firm and are doing business as Sands Capital. Sands Capital operates as a distinct business organization, retains discretion over the assets between the two registered investment advisers, and has autonomy over the total investment decision-making process.
Investment in a fund involves significant risk. The Life Sciences Pulse strategy is concentrated in a limited number of holdings in the life sciences industry. Some of the risks impacting this industry include cybersecurity risk, supply chain disruption, regulatory risk, geopolitical risk, cryptocurrency risk, intellectual property risk and product liability risk. The fund is also subject to risks related to investments in China. No assurance can be given that a fund’s investment objectives will be achieved. An investment is only suitable for sophisticated investors for whom an investment does not constitute a complete investment program, who have experience with similar types of investments, and who understand, are willing to assume, and have the financial resources necessary to withstand the significant risks involved in the investment, including the potential for a complete loss of capital. Please review the risks outlined in the Private Placement Memorandum prior to investing.
The activities of the Life Sciences Pulse Team, including investment due diligence and sourcing, may be supported on an ad hoc basis by various members of the broader global research team of Sands Capital Management. Please refer to the biographies of the Life Sciences Pulse Strategy Team members. Members of the Life Sciences Pulse team also provide services with respect to other strategies of Sands Capital.
The logos and website images used are used for illustrative purposes only and were obtained directly from the relevant companies’ websites. The logo and website images are trademarks or registered trademarks of the companies and their use on this webpage does not imply any connection between us and the companies.
Target investment size is current as of 3/31/2023